Viatris
Jeffrey Smith PhD is an experienced professional in the field of pharmacology and toxicology, currently serving as the Head of Preclinical and Toxicology and Head of Global Pharmacology and Toxicology at Viatris since November 2020. Prior to this role, Jeffrey held various positions at Mylan Inc. from 2005 to November 2020, including Vice President of Global Pharmacology, Toxicology and Business Development, and Director of Pharmacology and Toxicology. Earlier experience includes roles at Mylan Bertek Pharmaceuticals and Bertek Pharmaceuticals, where Jeffrey advanced from Senior Pharmacologist/Toxicologist to Assistant Director. Jeffrey began a career in clinical research as a Clinical Research Scientist at Mylan Pharmaceuticals and earned a Ph.D. in Pharmacology and Toxicology from West Virginia University School of Medicine and a BA in Chemistry from West Virginia University.
This person is not in any teams
This person is not in any offices
Viatris
42 followers
Viatris is a new kind of global healthcare company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, including a global workforce of approximately ~45,000, Viatris aims to deliver increased access to affordable, quality medicines for patients worldwide, regardless of geography or circumstance.